Dozens of experts and scholars presented research validating the liver-protective, hangover-alleviating, detoxifying functions of Antrodia cinnamomea. Additionally, the high safety profile of Antrodia cinnamomea mycelium in clinical applications for patients with Hepatitis B was highlighted and expected to increase its international recognition.

Dozens of experts and scholars presented research validating the liver-protective, hangover-alleviating, detoxifying functions of Antrodia cinnamomea. Additionally, the high safety profile of Antrodia cinnamomea mycelium in clinical applications for patients with Hepatitis B was highlighted and expected to increase its international recognition.

Greenyn Biotechnology received USFDA NDI acknowledgement without objection for Antrodia cinnamomea mycelia “Antromax”

Antromax® A. cinnamomea​ mycelia is the first USFDA-acknowledged A. cinnamomea​ product in the USA, and it is beneficial for improving liver function indexes and antioxidant capacity​ and immune modulation.